CCR5 and breast cancer: Eliminating palmitoylation reduces surface expression by trapping the receptor in organelles, where it is degraded.49,50 Better understanding of the role for palmitoylation in controlling surface-level expression of CCR5 in breast cancer cells could elucidate its role in mediating cancer cell interactions with other cell types that support the metastasis process.